CLOV - February 7, 2021
CLOV was bought out from a Chamath SPAC, this ticker has been in the headlines recently for investigation by the SEC for upping prices for healthcare services. Look for Chamath tweets and news on the stock to produce movement. From a technical standpoint, if we see a breakout look for resistance around 14.30 and 18 before moving higher with a 6-week price target of 24. Support is around 11.30, invalidation occurs around 12.20. CLOV has earnings coming up on February 25th, 2021 pre-market.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.